Livija Deban MA, PhD

Livija joined Prokarium in 2018 as the Chief Scientific Officer of Immunology and Oncology. She is leading the strategic and operational development of Prokarium’s immuno-oncology portfolio. As an immunologist, Livija specializes in mucosal and tumor immunology, immunological assay development, and immuno-oncology. Prior to joining Prokarium, Livija headed the lead selection and immuno-oncology R&D at Oxford BioTherapeutics where she focused on the target discovery and the development of immunomodulatory antibodies for cancer treatment. She has a MA in Medical Biotechnology and holds a Ph.D. in Basic and Applied Immunology. Livija conducted her research at Cancer Research UK and King’s College London before joining the biotech industry.